Add to ORKGIncludes bibliographical references (leaves 158-192).Ischaemic postconditioning (IPostC) is a powerful protective mechanism that activates prosurvival intrinsic signalling cascades to limit reperfusion injury but the exact signalling pathway involved in this cardioprotective effect still remains unclear
This thesis focuses on the potential of cell-based therapy in ischemic heart disease and the role of...
Ischaemic postconditioning (brief periods of ischaemia alternating with brief periods of reflow appl...
Contains fulltext : 57664.pdf (publisher's version ) (Closed access)Ischaemic prec...
Includes bibliographical references (leaves 73-89).Tumour necrosis factor alpha (TNFa) is a pleiotro...
Includes bibliographical references (leaves 150-177).Ischemic preconditioning is a protective mechan...
The pleiotropic cytokine tumour necrosis factor alpha (TNFα) is produced by the heart in response to...
High density lipoprotein cholesterol (HDL) and its component sphingosine-1-phosphate (S1P) protect a...
Copyright © 2012 Lydia Lacerda et al. This is an open access article distributed under the Creative ...
Since ischemic heart disease (IHD) is a major cause of mortality and heart failure, novel therapeuti...
Bibliographical references.Cardiac ischaemic preconditioning (IPC) describes a biological phenomenon...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Ischemia and trauma are two clinical problems characterized by a common response: inflammation and p...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
This thesis focuses on the potential of cell-based therapy in ischemic heart disease and the role of...
Ischaemic postconditioning (brief periods of ischaemia alternating with brief periods of reflow appl...
Contains fulltext : 57664.pdf (publisher's version ) (Closed access)Ischaemic prec...
Includes bibliographical references (leaves 73-89).Tumour necrosis factor alpha (TNFa) is a pleiotro...
Includes bibliographical references (leaves 150-177).Ischemic preconditioning is a protective mechan...
The pleiotropic cytokine tumour necrosis factor alpha (TNFα) is produced by the heart in response to...
High density lipoprotein cholesterol (HDL) and its component sphingosine-1-phosphate (S1P) protect a...
Copyright © 2012 Lydia Lacerda et al. This is an open access article distributed under the Creative ...
Since ischemic heart disease (IHD) is a major cause of mortality and heart failure, novel therapeuti...
Bibliographical references.Cardiac ischaemic preconditioning (IPC) describes a biological phenomenon...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Ischemia and trauma are two clinical problems characterized by a common response: inflammation and p...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosi...
This thesis focuses on the potential of cell-based therapy in ischemic heart disease and the role of...
Ischaemic postconditioning (brief periods of ischaemia alternating with brief periods of reflow appl...
Contains fulltext : 57664.pdf (publisher's version ) (Closed access)Ischaemic prec...